Impact of Septoplasty on HeadacheNCT07894575
Impact of Septoplasty on Headache
A study testing Septoplasty in people with Impact of Septoplasty on Headache, run by Sohag University at 1 site in Egypt.
Trial summary
Impact of septoplasty on headache if there is improvement or changes in headache severity before and after operation Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Impact of Septoplasty on Headache
- What is being tested?
- Septoplasty
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 20 Aug 2026to 20 Aug 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- age [18 - 60] years
- patients who have septal deviation and headache
Who cannot join
- Nasal diseases as Allergic rhinitis , Acute and chronic sinusitis , Nasal Polyps , granulomatous diseases , septal perforation
- Past history of nasal surgery
- systemic diseases as hypertension , diabetes , anemia , Blood diseases
- ophthalomological causes : Glaucoma ; Refractive errors.
- cervical spine and temporomandibular joint problems
- congential anomalies as Cleft lips or palate
Show all 9Show fewer
- neurological causes: vascular headache; tension headache; cluster headache ; migraine ; stroke ; epilepsy; tumors.
- dental causes: Untreated dental caries associated with pain ; teeth grinding ; recent dental procedures ; dental inflammation or abscess
- -
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Sohag university
Sohag
Sara Elia, 01210754828, Saraelia952@gmail.com
About this study
Impact of septoplasty on headache if there is improvement or changes in headache severity before and after operation
- Conditions
- Impact of Septoplasty on Headache
- Being tested
- Septoplasty
- Keywords
- Septoplasty; headache
- Medical subject headings
- Headache
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SeptoplastyProcedure or surgery
Surgical correction of the deviated nasal septum and evaluate its clinical impact on improving patients' headache
| Study group | Role | What they receive |
|---|---|---|
| Septoplasty group | Experimental | Patients with headache who will undergo septoplasty surgical procedure for setum deviation Receives: Procedure: Septoplasty |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Headache Severity before and after septoplasty
Headache severity will be assessed using the Visual Analogue Scale (VAS), where scores range from 0 (no pain) to 10 (worst possible pain). Higher scores indicate more severe headache.
Measured: Preoperatively and postoperatively at 1 month ; 3 month ; 6 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2026
- Study start20 Aug 2026
- Primary completion20 Aug 2027 (estimated)
- Study completion20 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Impact of Septoplasty on HeadacheStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sara Elia Adly, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07894575
- Sponsor's protocol ID
- Soh-Med-26-10-3MS
- Status last verified
- Oct 2026
- First submitted
- 19 Oct 2026
- Last updated
- 26 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Septoplasty on Headache
- ClinicalTrials.gov ID
- NCT07894575
- Acronym / sponsor ID
- Soh-Med-26-10-3MS
- Conditions
- Impact of Septoplasty on Headache
- Keywords
- Septoplasty; headache
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 20 Aug 2026 (actual)
- Primary completion
- 20 Aug 2027 (estimated)
- Study completion
- 20 Aug 2027 (estimated)
- First posted
- 26 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Impact of septoplasty on headache if there is improvement or changes in headache severity before and after operation
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Septoplasty group | Experimental | Procedure: SeptoplastyPatients with headache who will undergo septoplasty surgical procedure for setum deviation |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- age [18 - 60] years
- patients who have septal deviation and headache
Key exclusion criteria (9 listed)
- Nasal diseases as Allergic rhinitis , Acute and chronic sinusitis , Nasal Polyps , granulomatous diseases , septal perforation
- Past history of nasal surgery
- systemic diseases as hypertension , diabetes , anemia , Blood diseases
- ophthalomological causes : Glaucoma ; Refractive errors.
- cervical spine and temporomandibular joint problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SeptoplastySurgical correction of the deviated nasal septum and evaluate its clinical impact on improving patients' headache | Procedure or surgery | Septoplasty group |
Primary outcome
Change in Headache Severity before and after septoplasty
Time frame: Preoperatively and postoperatively at 1 month ; 3 month ; 6 month
Headache severity will be assessed using the Visual Analogue Scale (VAS), where scores range from 0 (no pain) to 10 (worst possible pain). Higher scores indicate more severe headache.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Septoplasty in people with Impact of Septoplasty on Headache, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Headache Severity before and after septoplasty (time frame: Preoperatively and postoperatively at 1 month ; 3 month ; 6 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.